These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26776591)

  • 1. Assessment of the responsiveness of the Cats' Assessment Tool for Cardiac Health (CATCH) Questionnaire.
    Rush JE; Roderick KV; Freeman LM; Cunningham SM; Yang VK; Bulmer BJ; Antoon KN
    J Vet Cardiol; 2015 Dec; 17 Suppl 1():S341-8. PubMed ID: 26776591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Survival Time and Changes in NT-proBNP in Cats Treated for Congestive Heart Failure.
    Pierce KV; Rush JE; Freeman LM; Cunningham SM; Yang VK
    J Vet Intern Med; 2017 May; 31(3):678-684. PubMed ID: 28370373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of a questionnaire for assessment of health-related quality of life in cats with cardiac disease.
    Freeman LM; Rush JE; Oyama MA; MacDonald KA; Cunningham SM; Bulmer B; MacGregor JM; Laste NJ; Malakoff RL; Hall DJ; Trafny DJ
    J Am Vet Med Assoc; 2012 May; 240(10):1188-93. PubMed ID: 22559108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of circulating N-terminal pro B-type natriuretic peptide concentration to differentiate between cardiac from noncardiac causes of pleural effusion in cats.
    Hassdenteufel E; Henrich E; Hildebrandt N; Stosic A; Schneider M
    J Vet Emerg Crit Care (San Antonio); 2013; 23(4):416-22. PubMed ID: 23859335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats.
    Fox PR; Rush JE; Reynolds CA; Defrancesco TC; Keene BW; Atkins CE; Gordon SG; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Macdonald KA; Lehmkuhl LB; Nguyenba TP; Sydney Moise N; Lefbom BK; Hogan DF; Oyama MA
    J Vet Intern Med; 2011; 25(5):1010-6. PubMed ID: 21985136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats.
    Wess G; Daisenberger P; Mahling M; Hirschberger J; Hartmann K
    Vet Clin Pathol; 2011 Jun; 40(2):237-44. PubMed ID: 21434959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating natriuretic peptides in cats with heart disease.
    Connolly DJ; Magalhaes RJ; Syme HM; Boswood A; Fuentes VL; Chu L; Metcalf M
    J Vet Intern Med; 2008; 22(1):96-105. PubMed ID: 18289295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of Cardiac from Noncardiac Pleural Effusions in Cats using Second-Generation Quantitative and Point-of-Care NT-proBNP Measurements.
    Hezzell MJ; Rush JE; Humm K; Rozanski EA; Sargent J; Connolly DJ; Boswood A; Oyama MA
    J Vet Intern Med; 2016; 30(2):536-42. PubMed ID: 26813037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-centered investigation of a point-of-care NT-proBNP ELISA assay to detect moderate to severe occult (pre-clinical) feline heart disease in cats referred for cardiac evaluation.
    Machen MC; Oyama MA; Gordon SG; Rush JE; Achen SE; Stepien RL; Fox PR; Saunders AB; Cunningham SM; Lee PM; Kellihan HB
    J Vet Cardiol; 2014 Dec; 16(4):245-55. PubMed ID: 25456274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating between feline pleural effusions of cardiac and non-cardiac origin using pleural fluid NT-proBNP concentrations.
    Humm K; Hezzell M; Sargent J; Connolly DJ; Boswood A
    J Small Anim Pract; 2013 Dec; 54(12):656-61. PubMed ID: 24283418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of an N-Terminal Prohormone of Brain Natriuretic Peptide Point-of-Care ELISA in Clinically Normal Cats and Cats With Cardiac Disease.
    Harris AN; Beatty SS; Estrada AH; Winter B; Bohannon M; Sosa I; Hanscom J; Mainville CA; Gallagher AE
    J Vet Intern Med; 2017 Jul; 31(4):994-999. PubMed ID: 28617995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of atenolol on NT-proBNP and troponin in asymptomatic cats with severe left ventricular hypertrophy because of hypertrophic cardiomyopathy: a pilot study.
    Jung SW; Kittleson MD
    J Vet Intern Med; 2011; 25(5):1044-9. PubMed ID: 21781160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [NT-proBNP as a diagnostic marker in dogs with dyspnea and in asymptomatic dogs with heart murmur].
    Haßdenteufel E; Kresken JG; Henrich E; Hildebrandt N; Schneider C; Stosic A; Schneider M
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(3):171-9. PubMed ID: 22688794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity.
    Oyama MA; Fox PR; Rush JE; Rozanski EA; Lesser M
    J Am Vet Med Assoc; 2008 May; 232(10):1496-503. PubMed ID: 18479239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of NT-pro-BNP assay on accuracy and confidence of general practitioners in diagnosing heart failure or respiratory disease in cats with respiratory signs.
    Singletary GE; Rush JE; Fox PR; Stepien RL; Oyama MA
    J Vet Intern Med; 2012; 26(3):542-6. PubMed ID: 22458368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiographic and biomarker evidence of plasma volume expansion after short-term steroids administered orally in cats.
    Block CL; Oyama MA
    J Vet Intern Med; 2020 Jan; 34(1):29-34. PubMed ID: 31816124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT-proBNP measurement fails to reliably identify subclinical hypertrophic cardiomyopathy in Maine Coon cats.
    Singh MK; Cocchiaro MF; Kittleson MD
    J Feline Med Surg; 2010 Dec; 12(12):942-7. PubMed ID: 21036088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-of-care N-terminal pro B-type natriuretic peptide assay to screen apparently healthy cats for cardiac disease in general practice.
    Lu TL; Côté E; Kuo YW; Wu HH; Wang WY; Hung YW
    J Vet Intern Med; 2021 Jul; 35(4):1663-1672. PubMed ID: 33993546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of a questionnaire for assessing health-related quality of life in dogs with cardiac disease.
    Freeman LM; Rush JE; Farabaugh AE; Must A
    J Am Vet Med Assoc; 2005 Jun; 226(11):1864-8. PubMed ID: 15934254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.